EMEA-002067-PIP02-17 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Nutrition
PIP number: P/0133/2017
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Emulsion for infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Fablyn
lasofoxifene
Osteoporosis, Postmenopausal
Date of authorisation:
Revision: 2
Last updated:
MedicineHumanLapsed
Lasofoxifene tartrate - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism
PIP number: P/1/2008
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman